Form 4: Centessa Pharmaceuticals CEO Saurabh Saha Reports Changes in Beneficial Ownership
SEC Form 4 Filing
CEO Saurabh Saha reports the withholding of shares to cover tax obligations and beneficial ownership through a trust.
Summary
- On September 30, 2024, Centessa Pharmaceuticals CEO Saurabh Saha reported changes in beneficial ownership of the company's ordinary shares.
- 36,263 shares were withheld by the issuer to cover tax withholding obligations related to the vesting of restricted share units at a price of $15.79.
- Following the transaction, Saha directly owns 685,661 ordinary shares.
- Saha also indirectly owns 38,000 ordinary shares through a trust where he and his spouse serve as trustees.
Sentiment
Score: 7
Explanation: The document reflects standard insider trading reporting, indicating normal corporate activity. The sentiment is neutral as it doesn't suggest any positive or negative implications for the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the withholding of shares for tax purposes, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of transaction involving the withholding of shares for tax obligations. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.